144 related articles for article (PubMed ID: 12434762)
1. T-20 (Fuzeon) gets priority review.
AIDS Treat News; 2002 Oct; (384):4-5. PubMed ID: 12434762
[No Abstract] [Full Text] [Related]
2. Three new drugs approved by FDA.
Hoyt G
Surviv News (Atlanta Ga); 2003; ():13, 20. PubMed ID: 14696579
[No Abstract] [Full Text] [Related]
3. Long path to approval. A look back at the road to Fuzeon.
GMHC Treat Issues; 2003 Mar; 17(3):1-5. PubMed ID: 12728856
[No Abstract] [Full Text] [Related]
4. Anti-HIV agents. T-20 (enfurvirtide, Fuzeon).
TreatmentUpdate; 2005; 17(1):5-6. PubMed ID: 17225316
[No Abstract] [Full Text] [Related]
5. Enfuvirtide (Fuzeon) for HIV Infection.
Med Lett Drugs Ther; 2003 Jun; 45(1159):49-50. PubMed ID: 12817195
[No Abstract] [Full Text] [Related]
6. First fusion inhibitor for advanced HIV.
Am J Nurs; 2003 Jul; 103(7):64F. PubMed ID: 12877130
[No Abstract] [Full Text] [Related]
7. Anti-HIV agents. Needle-free T-20.
TreatmentUpdate; 2005; 17(5):9-10. PubMed ID: 17219660
[No Abstract] [Full Text] [Related]
8. US FDA approves new class of HIV therapeutics.
Robertson D
Nat Biotechnol; 2003 May; 21(5):470-1. PubMed ID: 12721558
[No Abstract] [Full Text] [Related]
9. New class of medications approved for advance HIV.
FDA Consum; 2003; 37(3):5. PubMed ID: 12793380
[No Abstract] [Full Text] [Related]
10. Anti-HIV drug updates--three drugs on the near horizon.
Proj Inf Perspect; 2003 Jan; (35):4-7. PubMed ID: 12647672
[TBL] [Abstract][Full Text] [Related]
11. FDA notifications. Genentech issues letter about Fuzeon® co-product.
AIDS Alert; 2011 Apr; 26(4):47-8. PubMed ID: 21623626
[No Abstract] [Full Text] [Related]
12. [FDA approved the first of a new class of antiretrovirals for adults and children with advanced HIV infection].
Rev Panam Salud Publica; 2003 Jul; 14(1):57-8. PubMed ID: 12952609
[No Abstract] [Full Text] [Related]
13. T-1249 development suspended.
Huff B
GMHC Treat Issues; 2003 Dec; 17(12):6. PubMed ID: 15011643
[No Abstract] [Full Text] [Related]
14. European Commission approves Fuzeon following FDA approval--first HIV-fusion inhibitor in fight against HIV.
Infection; 2003 Aug; 31(4):7-8. PubMed ID: 14562955
[No Abstract] [Full Text] [Related]
15. Fusion inhibitor approved.
AIDS Patient Care STDS; 2003 May; 17(5):253. PubMed ID: 12816619
[No Abstract] [Full Text] [Related]
16. Fuzeon data review.
GMHC Treat Issues; 2003 Mar; 17(3):6. PubMed ID: 12728857
[No Abstract] [Full Text] [Related]
17. FUZEON (enfuvirtide, T-20). Breaking barriers or breaking the bank?
Sharp M; Camp R
GMHC Treat Issues; 2003 Mar; 17(3):7-8. PubMed ID: 12728858
[No Abstract] [Full Text] [Related]
18. T-20: entirely new antiretroviral.
James JS
AIDS Treat News; 1997 Sep; (No 279):5-6. PubMed ID: 11364691
[TBL] [Abstract][Full Text] [Related]
19. Drug cost. States concerned about Fuzeon.
AIDS Policy Law; 2003 Apr; 18(7):5. PubMed ID: 12728848
[No Abstract] [Full Text] [Related]
20. HIV medicine after Barcelona conference: interview with Howard Grossman, M.D. Interview by John S. James.
Grossman H
AIDS Treat News; 2002 Sep; (383):2-7. PubMed ID: 12765126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
